We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
In vitro Quality Assessment and Antibacterial Efficacy of Ciprofloxacin Tablets from Different Pharmaceutical Companies in Community Pharmacies in Iraq.
- Authors
Alzubaidi, Fatima Adnan; Al-Saigh, Rafal J.; Oubaid, Enass Najem; Liapi, Charis; Al-Humadi, Hussam W.
- Abstract
Introduction: Bioequivalence and bioavailability of antimicrobial drugs are considered as a critical issue in treatment of infectious diseases. Recently, some variations have been detected in clinical response to some antimicrobial agents. Ciprofloxacin is one of broad spectrum bactericidal agent that has been used widely in community which motivate us to assess its quality and quantity within available brands. Methods: Ciprofloxacin tablets from brand company (A) and other generic companies (B, C and D) have been selected, a standard powder in specific amount was dissolved and injected directly into HPLC to interpolate with the quantity of ciprofloxacin from each company tablet. In vitro dissolution rate was evaluated in every sample by calculating the difference and similarity factors. Antimicrobial effect was evaluated by minimum inhibitory concentration (MIC) method for reference strains of low to high level quinolone resistant bacteria. Results: Ciprofloxacin content was approved within accepted range for all companies except D that exceed the rang value. The dissolution testing was very rapid for A and B (>85%) within 15 minutes, while for D was <80% during the first 30 minutes. MIC for 24 hours of 0.128-500mg/L ciprofloxacin for all strains showed better results seen in A and B than D. Conclusion: Ciprofloxacin tablet of A, B and C companies were approved under the light of the quality test and antibacterial efficacy in comparison with D company, that urge for continuous monitoring and evaluation the generic drugs to avoid drug usefulness and antibiotic resistance.
- Subjects
IRAQ; CIPROFLOXACIN; PHARMACEUTICAL industry; ANTI-infective agents; GENERIC drugs; DRUG bioavailability; DRUGSTORES; DRUG resistance in bacteria
- Publication
Journal of Pharmaceutical Negative Results, 2022, Vol 13, Issue 2, p113
- ISSN
0976-9234
- Publication type
Article
- DOI
10.47750/pnr.2022.13.02.018